- Poster presentation
- Open Access
Interobserver variability of myocardial T1 and T2 mapping in patients with suspected myocarditis
© Luecke et al.; licensee BioMed Central Ltd. 2014
- Published: 16 January 2014
- Cardiovascular Magnetic Resonance
- Interobserver Variability
- Reference Region
- Mapping Sequence
The aim of this study was to test the interobserver variability of myocardial T1 and T2 Mapping prior to and T1 Mapping after the administration of contrast agent in patients with suspected myocarditis. The established methods for the detection of the presence of active inflammation - edema ratio (ER) and global relative enhancement (gRE) - require a "normal" reference region of interest (ROI) in adjacent skeletal muscle and depend on the choice of the muscle as well as its outline which can lead to high interobserver variability. Mapping techniques offer a quantitative approach without the need of a reference region.
27 patients (17 male, 10 female; mean age, 49 ± 19 years) with clinically suspected myocarditis underwent Cardiovascular Magnetic Resonance Imaging (CMR) at 1.5 T (Gyroscan Intera CV, Philips Medical Systems, Best, the Netherlands). The CMR assessment included midventricular single slice T1 maps before (T1pre) and after (T1post) the administration of contrast agent (TR = 2,75-2,9 ms, TE = 1,38-1,45 ms, TI = 168-6659 ms, slice thickness = 10 mm, FOV = 380 × 380 mm, Matrix = 320 × 320) and T2 maps (T2) without contrast (TR = 545,45-1200 ms, TE = 11,66 - 48,27 ms, TI = 250 ms, slice thickness = 8 mm, FOV = 370 × 370 mm, Matrix = 384 × 384) in short axis orientation. Interobserver correlation and Bland-Altman-analysis was performed.
Myocardial T1 Mapping prior to and after the administration of contrast agent and myocardial T2 Mapping show very low interobserver variability and could be observer independent tools to evaluate patients with myocarditis by CMR. The relative limits of agreement were with 2% of the mean narrow for all three mapping sequences.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.